|
⚲
|
| Keyboard |
| Fairmount Healthcare Fund II LP
✚
|
|
|---|---|
| CIK # | 0001769651 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001769651] | |
| 4 | [0001769651] | |
| D | [0001769651] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Damora Therapeutics Inc DMRA
Stock Option (right to buy) · derivative
|
2026-03-23 | Grant | 37,313 | $0.00 | |
|
Damora Therapeutics Inc GLTO
Common Stock
|
2026-02-09 | Option exercise | 5,809,000 | $0.00 | |
|
Damora Therapeutics Inc GLTO
Common Stock
|
2026-02-09 | Option exercise | 2,904,000 | $0.00 | |
|
Damora Therapeutics Inc GLTO
Series C Preferred Stock · derivative
|
2026-02-09 | Option exercise | 5,809 | $0.00 | |
|
Damora Therapeutics Inc GLTO
Series C Preferred Stock · derivative
|
2026-02-09 | Option exercise | 2,904 | $0.00 | |
|
Apogee Therapeutics Inc APGE
Common Stock
|
2026-01-22 | Sell | 1,750,000 | $76.30 | 133,525,000 |
|
Crescent Biopharma Inc CBIO
Pre-Funded Warrant (Right to Buy) · derivative
|
2025-12-04 | Buy | 131,434 | $13.41 | 1,762,530 |
|
Crescent Biopharma Inc CBIO
Ordinary Shares
|
2025-12-04 | Buy | 1,360,000 | $13.41 | 18,237,600 |
|
Miragen Therapeutics Inc VRDN
Common Stock
|
2025-10-23 | Buy | 454,545 | $22.00 | 9,999,990 |
|
Zenas BioPharma Inc ZBIO
Common Stock
|
2025-10-07 | Buy | 316,219 | $19.00 | 6,008,161 |
|
Jade Biosciences Inc JBIO
Common Stock
|
2025-10-06 | Grant | 1,333,126 | $9.14 | 12,184,772 |
|
Jade Biosciences Inc JBIO
Pre-Funded Warrant (Right to Buy) · derivative
|
2025-10-06 | Grant | 855,047 | $9.14 | 7,815,130 |
|
Crescent Biopharma Inc CBIO
Stock Option (Right to Buy) · derivative
|
2025-06-23 | Grant | 9,023 | $0.00 | |
|
Miragen Therapeutics Inc VRDN
Stock Option (Right to Buy) · derivative
|
2025-06-10 | Option exercise | 12,500 | $0.00 | |
|
Miragen Therapeutics Inc VRDN
Common Stock
|
2025-06-10 | Option exercise | 12,500 | $12.31 | 153,875 |
|
Zenas BioPharma Inc ZBIO
Stock Option (Right to Buy) · derivative
|
2025-06-10 | Grant | 18,500 | $0.00 | |
|
Miragen Therapeutics Inc VRDN
Common Stock
|
2025-06-09 | Option exercise | 1,600 | $7.80 | 12,480 |
|
Miragen Therapeutics Inc VRDN
Stock Option (Right to Buy) · derivative
|
2025-06-09 | Option exercise | 1,600 | $0.00 | |
|
Oruka Therapeutics Inc ORKA
Stock Option (Right to Buy) · derivative
|
2025-06-02 | Grant | 17,500 | $0.00 | |
|
Spyre Therapeutics Inc SYRE
Stock Option (Right to Buy) · derivative
|
2025-05-29 | Grant | 25,000 | $0.00 | |
| showing 20 of 71 most recent transactions | |||||